Welcome to our dedicated page for QHSLab SEC filings (Ticker: USAQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QHSLab, Inc. filings document a Nevada digital health issuer with Section 12(g) common stock traded under USAQ and no registered national exchange listing. Recent Form 8-K reports furnish Regulation FD press-release disclosures on Integrated Service Program growth, Q-Connect assessment launches, unaudited financial updates, fiscal results, and governance initiatives.
The company's material-event filings also record capital-structure transactions, including private placements of common stock and warrants, promissory note modifications, partial conversions, note repurchases, debt cancellation, and related unregistered sales of equity securities. These disclosures outline how QHSLab reports its financing activity, outstanding note obligations, common-stock issuance, and balance-sheet simplification alongside its digital health operating updates.
QHSLab, Inc. reported Q3 2025 results. Revenue was $737,066, up from $544,285 a year ago, with gross profit of $493,631 and a steady gross margin of 67.0%. Quarterly net income was $33,411, while for the nine months year‑to‑date the company recorded a net loss of $99,156 on revenue of $1,987,931 and gross margin of 66.5%.
Operating expenses rose to support growth, led by higher sales and marketing and increased R&D tied to the QHSLab platform. Cash was $158,391 as of September 30, 2025, against total current liabilities of $2,345,536. Accounts receivable, net, were $210,131.
The company disclosed substantial doubt about its ability to continue as a going concern. It is in default on an acquisition promissory note with $461,127 of principal and accrued interest outstanding, and received default notices on two OID convertible notes with remaining principal balances of $646,841 and $462,306; default interest is accruing at 18%. On November 13, 2025, shares outstanding were 11,281,527. Management notes continued efforts to grow Integrated Service Program revenues and to discuss note terms with the current holder.